Press release
Global Sterile Injectable Drugs Market, 2017—2024: Top Key Players: GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co.
Zion Market Research has published a new report titled “Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global sterile injectable drugs market was valued at approximately USD 369.7 billion in 2017 and is expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024.Request Free Sample Report Keyword @ https://goo.gl/29HTwX
The increasing preference for large molecule drugs over traditional drugs, rising incidences of chronic diseases, and the requirement of large molecules for the treatment of chronic diseases are major growth factors likely to fuel the sterile injectable drugs market in the future. The rise in the use of biologics, monoclonal antibodies, and antibody-drugs conjugate to treat various diseases is also anticipated to boost the development of this market globally in the estimated time period.
The sterile injectable drugs market is divided based on type, indication, drug class, and distribution channel. By type, the market is classified into large molecules and small molecules. Large molecules are anticipated to dominate the sterile injectable drugs market. The indication segment comprises musculoskeletal disorders, neurology, oncology, autoimmune, contagious diseases, cardiology and metabolic disorders, and others. Oncology is expected to dominate this market globally, due to the rising prevalence of cancer and research on the effective drugs for treating cancer. By drug class, the sterile injectable drugs market includes insulin, vaccine, peptide hormones, monoclonal antibodies, immunoglobulin, cytokines, blood factors, and others. Monoclonal antibodies are likely to lead this global market, as they can bind to the same epitope through monovalent affinity and carry drugs to help them in triggering the immune system for required responses. By distribution channel, the market includes hospital pharmacy, retail pharmacy, and e-commerce. Hospital pharmacies are projected to dominate the market in the future, owing to the major patient population in hospitals.
North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa comprise the regional segment of the global sterile injectable drugs market. The Asia Pacific is predicted to register the highest rate of growth in the sterile injectable drugs market, owing to the presence of a large patient pool, the presence of various small pharma companies in India and China, the introduction of different types of policies by various government bodies, and rising awareness about sterile injectable drugs. North America is projected to lead the market for sterile injectable drugs in the forecast time period, due to the rapid developments made in healthcare infrastructure, the presence of major players in the region, and huge investments made in the research and development. The increase in investment witnessed across the healthcare sector, the enforcement of strict government regulations for sterile injectable drugs, and rise in the prevalence of chronic diseases are likely to support this market in the European region.
Download Free PDF Research Report Brochure @ https://goo.gl/UyNqar
Major players of the sterile injectable drugs market include GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co., Inc., Gilead Sciences Inc., Pfizer Inc., Novartis AG, and Nova Nordisk A/S, among others.
This report segments the global sterile injectable drugs market into:
Global Sterile Injectable Drugs Market: Type Analysis
Small Molecules
Large Molecules
Global Sterile Injectable Drugs Market: Drug Class Analysis
Monoclonal Antibodies
Cytokines
Insulin
Peptide Hormones
Vaccine
Immunoglobulin
Blood Factors
Others
Global Sterile Injectable Drugs Market: Indication Analysis
Cardiology and Metabolic Disorders
Musculoskeletal Disorders
Neurology Disorders
Autoimmune
Oncology
Infectious Diseases
Others
Global Sterile Injectable Drugs Market: Distribution Channel Analysis
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Browse the full “Sterile Injectable Drugs Market” Report at https://goo.gl/hV6Y1a
Global Sterile Injectable Drugs Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Sterile Injectable Drugs Market, 2017—2024: Top Key Players: GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co. here
News-ID: 1499563 • Views: …
More Releases from zion market research

Distributed Energy Resource Management System (DERMS) Market Size to Reach USD 3 …
The global Distributed Energy Resource Management System (DERMS) market was valued at USD 615.24 Million in 2024 and is projected to reach USD 3,445.16 Million by 2034, growing at a remarkable CAGR of 18.8% between 2025 and 2034. The rapid integration of renewable energy, grid modernization initiatives, and supportive government policies are fueling the demand for advanced DERMS solutions worldwide.
A DERMS enables utilities and grid operators to efficiently manage distributed…

Video Surveillance As A Service (VSaaS) Market Size Worth USD 20.15 Billion by 2 …
The global video surveillance as a service (VSaaS) market was valued at USD 5.02 Billion in 2024 and is projected to reach USD 20.15 Billion by 2034, expanding at a CAGR of 14.9% between 2025 and 2034. With enterprises, governments, and households embracing cloud-based security, VSaaS has emerged as a transformative technology in global surveillance infrastructure. It provides cost-effective, scalable, and remotely accessible video monitoring, making it an attractive choice…

Automotive Engine Cooling System Market Size Worth USD 57.30 Billion by 2034, Gr …
The global automotive engine cooling system market was valued at USD 35.85 Billion in 2024 and is expected to reach USD 57.30 Billion by 2034, expanding at a CAGR of 4.8% between 2025 and 2034. Engine cooling systems play a vital role in maintaining engine temperature, ensuring efficiency, and enhancing vehicle performance. With the rise of electric vehicles (EVs), demand for advanced cooling solutions is expanding rapidly, creating new opportunities…

Wearable Technology Market to Surpass USD 365.32 Billion by 2034, Driven by Smar …
The global wearable technology market was valued at USD 89.26 billion in 2024 and is projected to reach USD 365.32 billion by 2034, growing at a CAGR of 13.8% between 2025 and 2034. The market growth is being fueled by rising consumer health consciousness, the popularity of fitness tracking devices, advancements in sensor technologies, and the integration of wearables into healthcare and consumer electronics ecosystems.
Wearable Technology Market Overview
Wearable technology refers…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…